Chris Boshoff

Pfizer's Chris Boshoff discusses the current state of American science and the role of science journalism. He describes an extraordinary, accelerating landscape driven by the convergence of biology, genomics, data science, and engineering, supported by an ecosystem where academia, government, and industry collaborate. He warns that sustaining investment in basic research and maintaining public trust in science are ongoing responsibilities. Boshoff highlights oncology, cardiometabolic disease, and immunology as areas of tangible progress in medicine. He also notes that artificial intelligence is reshaping science by enabling rapid knowledge synthesis and the design of complex molecules and vaccines, underscoring optimism about the future of American science.